Answer Every Question in One Swab.
Nine female-specific targets resolved in a single swab — chlamydia, gonorrhea, trich, Mgen, HSV-1/2, syphilis, chancroid, and Gardnerella — reported per-target in 24–48 hours.
Generic STI panels treat male and female anatomy as interchangeable. They aren't. A woman presenting with discharge or dysuria needs Trichomonas, Mycoplasma genitalium, and Gardnerella resolved in the same draw — not three separate send-outs across three different labs.
Our female panel covers nine targets that map directly to the differential a women's-health provider is actually working through, with PCR-grade sensitivity and 24–48 hour turnaround.
The clinical weight behind this panel.
Industry statistics from public-health bodies and peer-reviewed literature — context for why this testing matters.
Half occur in people aged 15–24.
PID is a leading preventable cause of infertility and ectopic pregnancy.
Screening — not symptoms — drives diagnosis.
Figures reflect publicly reported epidemiology and clinical literature for context only. They are not performance claims for the Chaseville Labs assay. See individual citations from the U.S. Centers for Disease Control and Prevention, World Health Organization, National Institutes of Health, and peer-reviewed journals.
Conditions, syndromes & infections covered.
The clinical scenarios where this panel is the right call — built around the differential your providers are actually working through.
Reportable Bacterial STIs
3The most common reportable STI in the U.S. — asymptomatic in up to 70% of women.
Cervicitis, PID, disseminated gonococcal infection, and neonatal conjunctivitis risk in pregnancy.
Emerging cause of cervicitis, PID, and urethritis — historically under-diagnosed.
Vaginitis & Reproductive Health
3Causes vaginitis, dyspareunia, and increases HIV acquisition risk.
Supports BV diagnosis when combined with clinical picture and Lactobacillus depletion.
Vaginal/rectal colonization during pregnancy.
Genital Herpes
2Increasingly the dominant cause of new genital herpes diagnoses, especially in younger patients.
Classic cause of recurrent genital ulcers; higher transmission and shedding risk.
9 targets, resolved from a single specimen.
Each organism below is reported individually as Detected, Not Detected, or Inconclusive — grouped here by pathogen class for clinical scanability.
Targets
8 targetsCulture was built for a different century.
Multiplex real-time PCR resolves what culture and rapid antigen miss — fastidious organisms, polymicrobial infections, viruses, and resistance markers — from a single specimen.
Culture & rapid antigen
- 3–5 daysPatient empirically treated before any answer arrives
- Misses fastidious & viral organismsNo growth ≠ no infection
- Single-organism biasPolymicrobial infections under-reported
- No resistance dataSusceptibilities arrive a day later, if at all
- Specimen-quality dependentPre-treated patients culture negative
STI Panel — Women on Bio-Rad CFX384
- 24–48 hoursMost reports back the next clinical day
- 9 targets, one runBacterial, viral, fungal, and parasitic in a single multiplex
- Detects what culture can'tFastidious organisms, viruses, and polymicrobial infections, all reported individually
- Validated LDTCLIA-certified, internally controlled, per-target Detected / Not Detected reporting
Per-target results, with clinical context.
Every analyte is reported individually as Detected, Not Detected, or Inconclusive. What a Detected result means clinically depends on which category the target falls into:
Each Detected result maps to a specific actionable diagnosis. CT, NG, Mgen, and Trichomonas are treated per CDC guidance; Gardnerella supports a BV diagnosis in the right clinical picture; HSV-1/2 typing guides recurrence counseling and suppression decisions; GBS detection informs intrapartum prophylaxis.